statistiche ricercatore

PERLETTI, GIANPAOLO

Distribuzione geografica

Continente	#
NA - Nord America	19.531
EU - Europa	9.084
AS - Asia	6.576
SA - Sud America	925
AF - Africa	352
Continente sconosciuto - Info sul continente non disponibili	255
OC - Oceania	168
Totale	36.891

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	19.036
IT - Italia	4.503
SG - Singapore	1.857
UA - Ucraina	1.255
CN - Cina	1.243
VN - Vietnam	805
BR - Brasile	719
TR - Turchia	687
SE - Svezia	671
HK - Hong Kong	648
GB - Regno Unito	531
IE - Irlanda	388
DE - Germania	359
FI - Finlandia	348
FR - Francia	313
CA - Canada	286
IN - India	274
RU - Federazione Russa	211
AU - Australia	136
BD - Bangladesh	130
ID - Indonesia	116
IQ - Iraq	110
PK - Pakistan	100
IR - Iran	96
NG - Nigeria	95
MX - Messico	92
ES - Italia	75
JP - Giappone	74
EG - Egitto	71
KR - Corea	66
AR - Argentina	64
PL - Polonia	64
NL - Olanda	61
ZA - Sudafrica	51
BE - Belgio	50
TH - Thailandia	49
TW - Taiwan	49
MY - Malesia	47
GR - Grecia	43
PH - Filippine	42
CO - Colombia	30
EC - Ecuador	30
NP - Nepal	30
NZ - Nuova Zelanda	29
PE - Perù	28
CR - Costa Rica	24
DZ - Algeria	23
CZ - Repubblica Ceca	22
JO - Giordania	22
AT - Austria	21
UG - Uganda	21
BG - Bulgaria	20
KE - Kenya	20
RS - Serbia	20
GH - Ghana	19
PT - Portogallo	19
SA - Arabia Saudita	18
IL - Israele	17
RO - Romania	17
MA - Marocco	16
UZ - Uzbekistan	16
VE - Venezuela	16
JM - Giamaica	15
CH - Svizzera	14
CL - Cile	14
LT - Lituania	14
AE - Emirati Arabi Uniti	13
EU - Europa	13
AL - Albania	10
HN - Honduras	10
PR - Porto Rico	10
QA - Qatar	10
TN - Tunisia	10
YE - Yemen	10
GT - Guatemala	9
UY - Uruguay	9
DK - Danimarca	8
HU - Ungheria	8
MD - Moldavia	8
NI - Nicaragua	8
SK - Slovacchia (Repubblica Slovacca)	8
BO - Bolivia	7
CW - ???statistics.table.value.countryCode.CW???	7
ET - Etiopia	7
SV - El Salvador	7
TT - Trinidad e Tobago	7
AZ - Azerbaigian	6
PY - Paraguay	6
SN - Senegal	6
CU - Cuba	5
DO - Repubblica Dominicana	5
EE - Estonia	5
GP - Guadalupe	5
LB - Libano	5
PS - Palestinian Territory	5
BB - Barbados	4
BH - Bahrain	4
LK - Sri Lanka	4
LV - Lettonia	4
BS - Bahamas	3
Totale	36.596

Salva come PNG Salva come JPEG

Città	#
Milan	2.848
Ashburn	1.852
Fairfield	1.592
San Jose	1.317
Singapore	1.072
Woodbridge	1.033
Jacksonville	957
Chandler	822
Houston	810
Seattle	696
Wilmington	622
Hong Kong	599
Council Bluffs	595
Cambridge	566
Ann Arbor	493
Dallas	445
Dublin	374
Princeton	368
Dearborn	343
Nyköping	337
Izmir	300
Beijing	299
Rome	287
Chicago	238
Boardman	235
The Dalles	228
Los Angeles	226
New York	225
Dong Ket	195
Lauterbourg	181
Ho Chi Minh City	169
Como	167
Santa Clara	161
San Mateo	122
San Diego	121
Hanoi	108
Orem	96
Atlanta	92
London	88
San Francisco	85
São Paulo	84
Ogden	77
Denver	73
Montreal	69
Toronto	67
Tokyo	58
Phoenix	57
Helsinki	56
Guangzhou	54
Brooklyn	53
Abuja	49
Shanghai	44
Warsaw	44
Verona	41
Munich	40
Washington	40
Chennai	39
Jakarta	39
Sydney	39
Manchester	37
Mexico City	37
Bangkok	36
Brisbane	36
Naples	36
Nanjing	35
Hefei	34
Kocaeli	33
Boston	31
Kunming	31
Cairo	30
Sulaymaniyah	29
Stockholm	28
Lahore	27
Las Vegas	26
Rio de Janeiro	25
Baghdad	24
Memphis	24
Mumbai	24
Pioltello	24
Moscow	23
Philadelphia	23
Portland	23
Johannesburg	22
Shenzhen	22
Amman	21
Catania	21
Lagos	21
Madrid	21
North Bergen	21
Rozzano	21
Tianjin	21
Brussels	20
Nuremberg	20
Bologna	19
Frankfurt am Main	19
Hangzhou	19
Kampala	19
Pune	19
Athens	18
Brasília	18
Totale	23.425

Salva come PNG Salva come JPEG

Nome	#
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials	1.159
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer	1.028
Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes	836
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials	721
Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials	713
Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis	367
The use of Lactobacillus casei DG® prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study	339
Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis	333
Risk of urinary stone formation associated to proton pump inhibitors: a systematic review and metanalysis	309
α-blockers and antibiotics, alone or in combination, improve symptoms in men with chronic prostatitis/chronic pelvic pain syndrome.	284
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	271
Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials	268
Serenoa repens and Pygeum Africanum in the treatment of BPH	257
The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women	255
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up	250
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOFORMS IN THE EARLY STAGES OF DIETHYLNITROSAMINE-INDUCED RAT HEPATOCARCINOGENESIS	246
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients	243
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.	240
Sexuality, Sexual Orientation and Chronic Prostatitis	240
Erectile and Ejaculatory Dysfunction Associated with Use of Psychotropic Drugs: A Systematic Review	239
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay	238
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	232
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity	231
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene.	230
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.	228
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting	227
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).	225
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil	220
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction.	220
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin?	220
Anti-infective treatment of bacterial urinary tract infections.	217
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.	216
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses.	215
Chronic bacterial prostatitis: enterococcal disease?	215
A new approach to the direct detection of free radicals in the intact myocardium.	214
Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation	212
Antimicrobials in urogenital infections.	210
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis	209
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	207
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy.	207
Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study	207
p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells	205
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications.	205
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations.	205
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study.	204
Antimicrobial therapy for chronic bacterial prostatitis.	203
Azithromycin: mechanisms of action and their relevance for clinical applications.	203
Computer-assisted quantitative assessment of prostatic calcifications in patients with chronic prostatitis	203
Prevalence of erectile and ejaculatory dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome	202
Finafloxacin for the treatment of urinary tract infections	201
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review).	198
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis	197
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review)	196
National institute of health chronic prostatitis symptom index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients	196
FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer	194
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure.	192
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate	192
Herbal medicines for urinary stone treatment. A systematic review	190
Lithogenic Potential of Ureaplasma in Chronic Prostatitis	190
Collagen organization in leech wound healing.	189
Structure and function of the extraembryonic membrane persisting around the larvae of the parasitoid Toxoneuron nigriceps.	189
Prevention and modulation of aminoglycoside ototoxicity (Review)	189
INTERACTION OF CU(II) AND CU(II)-ANTHRACYCLINE COMPLEXES WITH PROTEIN-KINASE-C - SPECTROMAGNETIC ASSESSMENT OF THE INHIBITORY EFFECT	187
Epidemiology of urolithiasis in Europe and Latin America: A systematic review	183
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.	182
Leech responses to tissue transplantation	182
Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity.	179
DIFFERENTIAL PHORBOL ESTER GROWTH MODULATION AND PROTEIN-KINASE-C ISOENZYME EXPRESSION IN RAT HEPATOMA-CELLS VS NON NEOPLASTIC RAT HEPATOCYTES	178
PROTECTIVE EFFECTS OF SPIN-TRAPPING AGENTS ON ADRIAMYCIN-INDUCED CARDIOTOXICITY IN ISOLATED RAT ATRIA	178
Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer	178
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model	177
Emerging drugs for bacterial urinary tract infections.	177
Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth	176
PROTEIN-KINASE-C ISOZYME PATTERN IN LIVER HYPERPLASIA	176
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study.	176
PROTEIN-KINASE-C ISOZYMES DURING LIVER-REGENERATION	174
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOENZYMES IN INTRINSICALLY RESISTANT CLONED LINES OF LOVO CELLS - REVERSAL OF RESISTANCE BY KINASE INHIBITOR 1-(5-ISOQINOLINYLSULFONYL) 2-METHYLPIPERAZINE	173
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation.	173
Lentivirus-mediated RNA interference of Ku70 to enhance radiosensitivity of human mammary epithelial cells: Implications for breast cancer onset.	172
VEGF stimulates angiogenesis in Hirudo medicinalis.	172
Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity.	172
Risk factors analysis in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from Finland, Germany, Italy and Switzerland: Results of a multinational observational study	172
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients	171
THE INHIBITORY EFFECT OF CU(II) ON PROTEIN-KINASE-C IS ENHANCED BY ANTHRACYCLINES - AN ESR STUDY	169
Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study	169
Anti-cancer potential of edible/medicinal mushrooms in breast cancer	168
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome	168
Distinctive cellular roles for novel protein kinase C isoenzymes	168
Effect of doxorubicin on calcium receptors of myocardial cells.	168
Re: Samplaski et al.: Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. (Urology 2011;78:653-658).	168
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study	168
Early suppression of immune response in Heliothis virescens larvae by the endophagous parasitoid Toxoneuron nigriceps	168
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.	166
I fitoterapici nella prevenzione e terapia del carcinoma prostatico	166
Wound repair in Hirudo medicinalis: phases and response modulation	165
PARTIAL-PURIFICATION OF PROTEIN-KINASE-C ISOENZYMES FROM RAT-LIVER	165
Multidisciplinary approach to prostatitis	165
Hirudo medicinalis: a new model system for testing activators and inhibitors of angiogenesis	164
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV	164
THE ACTIVITY OF A BETA-SUBTYPE OF PROTEIN-KINASE-C PURIFIED FROM NUCLEI OF HUMAN NEUTROPHILS IS ENHANCED BY TREATMENT WITH PHORBOL 12-MYRISTATE 13-ACETATE	163
Totale	23.881

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	136.062
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	136.062

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.461	0	0	0	173	31	99	82	152	258	240	154	272
2022/2023	2.265	262	122	235	199	170	488	3	284	285	79	75	63
2023/2024	4.839	675	731	765	812	905	256	60	109	148	118	117	143
2024/2025	4.058	136	145	605	134	184	221	176	303	417	422	404	911
2025/2026	8.399	608	494	440	1.054	749	468	1.580	558	829	606	444	569
2026/2027	4.840	1.447	656	1.359	1.378	0	0	0	0	0	0	0	0
Totale													36.891